These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3179212)

  • 1. Suitability of the upper back for corticosteroid vasoconstrictor assay.
    Duhra P; Ryatt KS
    Br J Dermatol; 1988 Sep; 119(3):406-7. PubMed ID: 3179212
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of admixture of commercially available corticosteroid ointments and/or creams on vasoconstrictor activity].
    Ohtani M; Yamada N; Takayama K; Kotaki H; Etoh T; Kariya S; Uchino K; Iga T
    Yakugaku Zasshi; 2002 Jan; 122(1):107-12. PubMed ID: 11828745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laser-Doppler flowmetric study.
    Andersen P; Milioni K; Maibach H
    Br J Dermatol; 1993 Jun; 128(6):660-5. PubMed ID: 8338750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary skin blood flow measurements appear unsuccessful for assessing topical corticosteroid effect.
    Amantea M; Tur E; Maibach HI; Guy RH
    Arch Dermatol Res; 1983; 275(6):419-20. PubMed ID: 6660915
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the permeability of corticosteroid in hairless mouse and hairless micropig skin from admixture of commercially available corticosteroid ointments and/or creams].
    Ohtani M; Kotaki H; Kariya S; Uchino K; Iga T
    Yakugaku Zasshi; 2002 Aug; 122(8):589-94. PubMed ID: 12187775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dermatologic corticosteroid therapy up-date. Corticosteroid administration in dermatology].
    Crespi HG
    Actas Dermosifiliogr; 1981; 72(3-4):101-10. PubMed ID: 7032244
    [No Abstract]   [Full Text] [Related]  

  • 7. [Corticosteroid effect and vasoconstriction. 2. Influencing the antipsoriatic corticosteroid effect by suppression of vasoconstriction].
    Maucher OM; Brehm K
    Arzneimittelforschung; 1972 Jun; 22(6):1039-43. PubMed ID: 4559155
    [No Abstract]   [Full Text] [Related]  

  • 8. Extemporaneous dilutions of proprietary topical corticosteroid preparations.
    Kirsch JM; Gibson JR; Darley C; Barrett CW
    Dermatologica; 1982 Jul; 165(1):71-2. PubMed ID: 7117653
    [No Abstract]   [Full Text] [Related]  

  • 9. Forearm site variation with the corticosteroid vasoconstrictor assay.
    Kirsch J; Gibson JR; Darley CR; Barth J; Burke CA
    Br J Dermatol; 1982 Apr; 106(4):495. PubMed ID: 7073976
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter.
    Queille-Roussel C; Poncet M; Schaefer H
    Br J Dermatol; 1991 Mar; 124(3):264-70. PubMed ID: 2018732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The topical corticosteroid classification called into question: towards a new approach.
    Humbert P; Guichard A
    Exp Dermatol; 2015 May; 24(5):393-5. PubMed ID: 25707534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of the vasoconstrictive effect of steroid prepartions for external use by means of remitometric photoplethysmography].
    Rovenský J; Záhejský J
    Cesk Dermatol; 1973 Dec; 48(6):361-6. PubMed ID: 4771778
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of an objective method for assessing topical corticosteroid efficacy.
    Trikam DS; Morton DJ
    Cent Afr J Med; 1985 Nov; 31(11):228-9. PubMed ID: 3830402
    [No Abstract]   [Full Text] [Related]  

  • 14. An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations.
    Gibson JR; Kirsch JM; Darley CR; Harvey SG; Burke CA; Hanson ME
    Br J Dermatol; 1984 Jul; 111 Suppl 27():204-12. PubMed ID: 6378245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural skin colour changes during the corticosteroid blanching assay.
    Henry F; Fumal I; Piérard GE
    Skin Pharmacol Appl Skin Physiol; 1999; 12(4):199-210. PubMed ID: 10420140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Corticosteroid Treatment of Refractory Spontaneous Vasoconstriction of Extracranial Internal Carotid and Coronary Arteries.
    Takeuchi M; Saito K; Kajimoto K; Nagatsuka K
    Neurologist; 2016 Jul; 21(4):55-7. PubMed ID: 27348139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
    Brehm K; Maucher OM
    Arzneimittelforschung; 1972 Jun; 22(6):1038-9. PubMed ID: 5068352
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the contractile activity of the portal vein of the rat in response to corticosteroid hormones].
    Ovchinnikova LP; Barabanova VV; Shaliapina VG
    Fiziol Zh SSSR Im I M Sechenova; 1986 Nov; 72(11):1528-32. PubMed ID: 3817192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Br J Dermatol; 1983 Jul; 109 Suppl 25():114-6. PubMed ID: 6860578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-dependent differences in the pharmacodynamic effect of topically applied Corticosteroids].
    Koch EM; Ott R; Koehler CO
    Arzneimittelforschung; 1986 Oct; 36(10):1540-4. PubMed ID: 3814215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.